Leo Groenewegen
Amministratore Delegato presso NBAB, Nordic BioAnalysis AB
Posizioni attive di Leo Groenewegen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
NBAB, Nordic BioAnalysis AB
 NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Amministratore Delegato | 01/09/2022 | - |
Storia della carriera di Leo Groenewegen
Precedenti posizioni note di Leo Groenewegen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NEXTCELL PHARMA AB | Direttore Finanziario/CFO | - | - |
| Corporate Officer/Principal | - | 01/09/2019 |
Statistiche
Distribuzione geografica
| Svezia | 3 |
Posizioni
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NEXTCELL PHARMA AB | Health Technology |
| Aziende private | 1 |
|---|---|
NBAB, Nordic BioAnalysis AB
NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Health Technology |
- Borsa valori
- Insiders
- Leo Groenewegen
- Esperienza
